Sidley Austin is advising GlycoMimetics, Inc. on the transaction, and Gibson, Dunn & Crutcher is advising Crescent Biopharma, Inc. GlycoMimetics, Inc. (NASDAQ: GLYC) announced it has...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers represented American Honda Finance Corporation in the offering, and Sidley Austin represented the underwriters. American Honda Finance Corporation announced its €750 million (appr....
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Contineum Therapeutics in the offering, and Sidley Austin represented the underwriters. Contineum Therapeutics, a clinical stage biopharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Athene Holding Ltd. in the offering, and Fried, Frank, Harris, Shriver & Jacobson represented the underwriters. Athene Holding Ltd. (Athene) (NYSE: ATHS) announced its...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Pyxis Oncology, Inc. on the deal. Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company, announced that it agreed to sell 8,849,371 shares of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Kimco Realty while Sidley advised the agents. Kimco Realty Corporation (NYSE: KIM) has priced a public offering of $500 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Synchrony Financial, and Davis Polk advised the joint book-running managers. Synchrony Financial announced an SEC-registered offering of $750 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
